In summary, in the largest randomised trial in chemonaïve patients with recurrent high grade glioma we were able to demonstrate the independent prognostic significance of IDH1/2 and MGMT methylation status, and potentially PTEN status, for survival. This evidence concerns the gene PTEN and central nervous system cancer.